BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19750480)

  • 1. Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.
    Zhang Z; Cherryholmes G; Chang F; Rose DM; Schraufstatter I; Shively JE
    Eur J Immunol; 2009 Nov; 39(11):3181-94. PubMed ID: 19750480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.
    Hu N; Westra J; Rutgers A; Doornbos-Van der Meer B; Huitema MG; Stegeman CA; Abdulahad WH; Satchell SC; Mathieson PW; Heeringa P; Kallenberg CG
    Arthritis Res Ther; 2011; 13(6):R201. PubMed ID: 22152684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2.
    Rose JJ; Foley JF; Murphy PM; Venkatesan S
    J Biol Chem; 2004 Jun; 279(23):24372-86. PubMed ID: 15028716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
    Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
    J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies.
    Tanaka K; Yoshitomi T; Hirahara K
    Biol Pharm Bull; 2017; 40(5):729-732. PubMed ID: 28458362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2.
    Doroshenko T; Chaly Y; Savitskiy V; Maslakova O; Portyanko A; Gorudko I; Voitenok NN
    Blood; 2002 Oct; 100(7):2668-71. PubMed ID: 12239185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β.
    Jablonska J; Wu CF; Andzinski L; Leschner S; Weiss S
    Int J Cancer; 2014 Mar; 134(6):1346-58. PubMed ID: 24154944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.
    Sogawa Y; Ohyama T; Maeda H; Hirahara K
    Immunology; 2011 Mar; 132(3):441-50. PubMed ID: 21039475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
    De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
    J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
    Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
    Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
    Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
    J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
    de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
    Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase
    Hemshekhar M; Choi KG; Mookherjee N
    Front Immunol; 2018; 9():1871. PubMed ID: 30158931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
    Zaslaver A; Feniger-Barish R; Ben-Baruch A
    J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
    Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
    Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection?
    Schmausser B; Josenhans C; Endrich S; Suerbaum S; Sitaru C; Andrulis M; Brändlein S; Rieckmann P; Müller-Hermelink HK; Eck M
    Infect Immun; 2004 Dec; 72(12):6773-9. PubMed ID: 15557597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
    Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
    J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.